A Furlan

Summary

Affiliation: Cleveland Clinic Foundation
Country: USA

Publications

  1. ncbi Patent foramen ovale and stroke: to close or not to close?
    Anthony J Furlan
    Department of Neurology, Cleveland Clinic, Cleveland, OH 44195, USA
    Cleve Clin J Med 74:S118-20. 2007
  2. ncbi Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism
    A Furlan
    Cerebrovascular Center, Department of Neurology, Cleveland Clinic Foundation, Ohio 44195, USA
    JAMA 282:2003-11. 1999
  3. ncbi Intra-arterial thrombolysis for acute stroke
    Anthony Furlan
    Section of Stroke and Neurologic Intensive Care, Department of Neurology, The Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Cleve Clin J Med 71:S31-8. 2004
  4. ncbi Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS): evidence of safety and efficacy 3 to 9 hours after stroke onset
    Anthony J Furlan
    Department of Neurology, The Cleveland Clinic, Cleveland, OH 44195, USA
    Stroke 37:1227-31. 2006
  5. ncbi The role of recombinant pro-urokinase (r-pro-UK) and intra-arterial thrombolysis in acute ischaemic stroke: the PROACT trials. Prolyse in Acute Cerebral Thromboembolism
    Anthony J Furlan
    Curr Med Res Opin 18:s44-7. 2002
  6. ncbi Patent foramen ovale and recurrent stroke: closure is the best option: yes
    Anthony J Furlan
    Department of Neurology, Cleveland Clinic, Cerebrovascular Center, Cleveland, Ohio, 44195-5001, USA
    Stroke 35:803-4. 2004
  7. ncbi Enhancing the development and approval of acute stroke therapies: Stroke Therapy Academic Industry roundtable
    Marc Fisher
    UMass Memorial Healthcare Center, 119 Belmont St, Worcester, MA 01605, USA
    Stroke 36:1808-13. 2005
  8. ncbi Quality improvement for stroke management at the Cleveland Clinic Health System
    Eric D Hixson
    Measurement Services, The Quality Institute, Cleveland Clinic Health System, Cleveland, USA
    Jt Comm J Qual Patient Saf 31:447-54. 2005
  9. ncbi Multimodal therapy for the treatment of severe ischemic stroke combining GPIIb/IIIa antagonists and angioplasty after failure of thrombolysis
    Alex Abou-Chebl
    Department of Neurology, The Cleveland Clinic Foundation, Cleveland, OH 44195, USA
    Stroke 36:2286-8. 2005
  10. ncbi IV tissue plasminogen activator for stroke in the community: what we know and don't know 10 years after FDA approval
    Anthony J Furlan
    Stroke 37:281. 2006

Collaborators

Detail Information

Publications25

  1. ncbi Patent foramen ovale and stroke: to close or not to close?
    Anthony J Furlan
    Department of Neurology, Cleveland Clinic, Cleveland, OH 44195, USA
    Cleve Clin J Med 74:S118-20. 2007
  2. ncbi Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism
    A Furlan
    Cerebrovascular Center, Department of Neurology, Cleveland Clinic Foundation, Ohio 44195, USA
    JAMA 282:2003-11. 1999
    ..Intravenous tissue-type plasminogen activator can be beneficial to some patients when given within 3 hours of stroke onset, but many patients present later after stroke onset and alternative treatments are needed...
  3. ncbi Intra-arterial thrombolysis for acute stroke
    Anthony Furlan
    Section of Stroke and Neurologic Intensive Care, Department of Neurology, The Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Cleve Clin J Med 71:S31-8. 2004
  4. ncbi Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS): evidence of safety and efficacy 3 to 9 hours after stroke onset
    Anthony J Furlan
    Department of Neurology, The Cleveland Clinic, Cleveland, OH 44195, USA
    Stroke 37:1227-31. 2006
    ..This study evaluated safety and efficacy of intravenous (IV) desmoteplase in patients with perfusion/diffusion mismatch on MRI 3 to 9 hours after onset of acute ischemic stroke...
  5. ncbi The role of recombinant pro-urokinase (r-pro-UK) and intra-arterial thrombolysis in acute ischaemic stroke: the PROACT trials. Prolyse in Acute Cerebral Thromboembolism
    Anthony J Furlan
    Curr Med Res Opin 18:s44-7. 2002
    ..However the American Heart Association has deemed IA thrombolysis an 'acceptable alternative therapy' and many stroke centres are offering it to patients with a major acute stroke presenting within 6 h...
  6. ncbi Patent foramen ovale and recurrent stroke: closure is the best option: yes
    Anthony J Furlan
    Department of Neurology, Cleveland Clinic, Cerebrovascular Center, Cleveland, Ohio, 44195-5001, USA
    Stroke 35:803-4. 2004
  7. ncbi Enhancing the development and approval of acute stroke therapies: Stroke Therapy Academic Industry roundtable
    Marc Fisher
    UMass Memorial Healthcare Center, 119 Belmont St, Worcester, MA 01605, USA
    Stroke 36:1808-13. 2005
    ..A fourth (STAIR-IV) was held to discuss relevant issues related to acute stroke drug development and regulatory approval...
  8. ncbi Quality improvement for stroke management at the Cleveland Clinic Health System
    Eric D Hixson
    Measurement Services, The Quality Institute, Cleveland Clinic Health System, Cleveland, USA
    Jt Comm J Qual Patient Saf 31:447-54. 2005
    ..Improvement activities included professional education, public awareness, process improvement, focused data collection with routine feedback, protocol refinement, and coordination of clinical personnel within and between hospitals...
  9. ncbi Multimodal therapy for the treatment of severe ischemic stroke combining GPIIb/IIIa antagonists and angioplasty after failure of thrombolysis
    Alex Abou-Chebl
    Department of Neurology, The Cleveland Clinic Foundation, Cleveland, OH 44195, USA
    Stroke 36:2286-8. 2005
    ..9+/-8.7) and 6 (50%) had an NIHSS < or =4 at discharge. CONCLUSIONS: Multimodal rescue therapy was effective at recanalizing occluded cerebral vessels that failed thrombolysis without an excess risk of ICH...
  10. ncbi IV tissue plasminogen activator for stroke in the community: what we know and don't know 10 years after FDA approval
    Anthony J Furlan
    Stroke 37:281. 2006
  11. ncbi Sex-based differences in the effect of intra-arterial treatment of stroke: analysis of the PROACT-2 study
    Michael D Hill
    Calgary Stroke Program, Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada
    Stroke 37:2322-5. 2006
    ..In a combined analysis of the tissue plasminogen activator clinical trials, a sex-by-treatment interaction was observed. We sought to confirm that observation in an independent data set...
  12. ncbi Recanalization of an acute middle cerebral artery occlusion using a self-expanding, reconstrainable, intracranial microstent as a temporary endovascular bypass
    Michael E Kelly
    Division of Cerebrovascular and Endovascular Neurosurgery, Department of Neurosurgery, Cleveland Clinic, S80, Cleveland, OH 44195, USA
    Stroke 39:1770-3. 2008
    ..We describe a technique in which a reconstrainable stent was used to provide a temporary endovascular bypass to achieve MCA recanalization without permanent stent implantation...
  13. ncbi Utilization of intravenous tissue plasminogen activator for acute ischemic stroke
    Irene L Katzan
    Department of Neurology, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Arch Neurol 61:346-50. 2004
    ..Intravenous tissue plasminogen activator (tPA) is the only approved therapy for acute ischemic stroke, although only 2% of patients with stroke receive intravenous tPA nationally...
  14. ncbi Computed tomographic findings in patients undergoing intra-arterial thrombolysis for acute ischemic stroke due to middle cerebral artery occlusion: results from the PROACT II trial
    Heidi C Roberts
    Department of Radiology, University of California, San Francisco, USA
    Stroke 33:1557-65. 2002
    ..The purpose of this study was to evaluate the role of noncontrast CT in the selection of patients to receive thrombolytic therapy for acute ischemic stroke and to predict radiological and clinical outcomes...
  15. ncbi Acute stroke therapy: beyond i.v. tPA
    Anthony J Furlan
    Cerebrovascular Center, Department of Neurology, The Cleveland Clinic Foundation, OH 44195, USA
    Cleve Clin J Med 69:730-4. 2002
    ..Several medical centers are turning to angiography to guide intra-arterial infusion of thrombolytic agents and mechanical endovascular interventions...
  16. ncbi Cuyahoga County Operation Stroke speed of emergency department evaluation and compliance with National Institutes of Neurological Disorders and Stroke time targets
    Irene L Katzan
    MetroHealth Medical Center, Cleveland Clinic Foundation, Ohio 44109 1998, USA
    Stroke 34:994-8. 2003
    ..To track compliance with NINDS guidelines, Cuyahoga County Operation Stroke implemented a countywide data collection process that provides comparative reporting of hospital performance...
  17. ncbi Quality improvement and tissue-type plasminogen activator for acute ischemic stroke: a Cleveland update
    Irene L Katzan
    Department of Neurology, Cleveland Clinic Foundation, 9500 Euclid Ave, S91, Cleveland, Ohio 44195, USA
    Stroke 34:799-800. 2003
    ..We now report updated results of intravenous tPA use in the Cleveland Clinic Health System (CCHS)...
  18. ncbi Factors influencing outcome and treatment effect in PROACT II
    Lawrence R Wechsler
    University of Pittsburgh, Pittsburgh, PA, USA
    Stroke 34:1224-9. 2003
    ..The purpose of the current study was to examine baseline factors to determine predictors of good outcome and response to treatment...
  19. ncbi Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke
    Randall T Higashida
    University of California, San Francisco Medical Center, Department of Radiology, 505 Parnassus Ave, Rm L 352, San Francisco, CA 94143 0628, USA
    Stroke 34:e109-37. 2003
    ....
  20. ncbi Training, competency, and credentialing standards for diagnostic cervicocerebral angiography, carotid stenting, and cerebrovascular intervention: a joint statement from the American Academy of Neurology, the American Association of Neurological Surgeons,
    John J Connors
    Baptist Cardiac and Vascular Institute, Baptist Hospital Miami, 8900 N. Kendall Avenue, Miami, FL 33133, USA
    Neurology 64:190-8. 2005
  21. ncbi Devices, drugs, and the Food and Drug Administration: increasing implications for ischemic stroke
    Anthony J Furlan
    Department of Neurology, University of Massachusetts Medical School, Worcester, Mass 01605-2982, USA
    Stroke 36:398-9. 2005
  22. ncbi Training, competency, and credentialing standards for diagnostic cervicocerebral angiography, carotid stenting, and cerebrovascular intervention: a joint statement from the American Academy of Neurology, the American Association of Neurological Surgeons,
    John J Connors
    Interventional Neuroradiology, Miami Cardiac and Vascular Institute, FL 33176, USA
    J Vasc Interv Radiol 15:1347-56. 2004
  23. ncbi Time is brain
    Anthony J Furlan
    Stroke 37:2863-4. 2006
  24. ncbi Acute stroke trials: strengthening the underpowered
    Anthony J Furlan
    Stroke 33:1450-1. 2002
  25. ncbi Training, competency, and credentialing standards for diagnostic cervicocerebral angiography, carotid stenting, and cerebrovascular intervention: a joint statement from the American Academy of Neurology, American Association of Neurological Surgeons, Amer
    John J Connors
    Radiology 234:26-34. 2005